Understanding GLP-1 Therapies Through WHOOP: A Groundbreaking Look at Heart Health and Physical Activity
At WHOOP, we’ve conducted groundbreaking research using wearable technology to explore how GLP-1 therapies influence overall health and fitness beyond weight loss. Originally developed for type 2 diabetes, GLP-1 medications have gained recognition for their transformative effects on weight management. About one in eight adults (12%) say they have used a GLP-1 . However, these therapies have complex effects on heart health, like causing an increase in resting heart rate (RHR). Our findings reveal that incorporating physical activity, as recommended by the FDA, can play a vital role in reducing the risk of increase in RHR associated with these therapies, highlighting the importance of an active lifestyle for long-term health outcomes. This research was published in the American Journal of Physiology - Heart and Circulatory Physiology. WHOOP provides the insights and support you need to make meaningful changes, whether you are focused on weight management, fitness, or overall health. By i
Topics Article Metabolic Health GLP-1 Therapies, Heart Health, and Exercise | WHOOP May 29, 2026 GLP-1 therapies have transformed weight management and metabolic health, but their effects extend far beyond the scale. At WHOOP, we've conducted groundbreaking research using wearable technology to explore how these medications influence cardiovascular health and physical activity—revealing insights that can help you optimize your health outcomes while using these therapies. Originally developed for type 2 diabetes, GLP-1 medications have gained recognition for their ability to support significant
Explore this link on the map →related reading
- If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?derekthompson.org
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
- The Worst Argument Against Ozempic - Cremieux Recueilcremieux.xyz
- Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players - farmdoc dailyfarmdocdaily.illinois.edu
- American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | American Society of Anesthesiologists (ASA)asahq.org
- Effect of 48 h Fasting on Autonomic Function, Brain Activity, Cognition, and Mood in Amateur Weight Lifters - PMCncbi.nlm.nih.gov
- Kristen Holmes Anchors WHOOP in Elite Performance As Brand Broadens Reach - Newsweeknewsweek.com
- Telehealth for Weight Loss, Hair Loss, Skin & More | Mochi Healthjoinmochi.com
- Why WHOOP Stands Behind Blood Pressure Insightswhoop.com
- Whoop 5.0 Review: A Wellness Expert’s Honest Verdict | The Independentthe-independent.com
- Semaglutide - Wikipediaen.wikipedia.org
- Towards passive heart health monitoring via smartphone cameraresearch.google